An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2)
Completed · Phase 3 · Has a placebo group
Conditions studied: Thyroid Eye Disease
In brief
This is a clinical trial assessing the efficacy, safety, and tolerability of an investigational drug, veligrotug (VRDN-001), in participants with chronic thyroid eye disease (TED).
Key facts
- Study ID
- NCT06021054
- Run by
- Viridian Therapeutics, Inc.
- People needed
- 188
- Starts
- 2023-11-14
- Expected to finish
- 2025-07-25
- Last updated by the study team
- 2025-10-23
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- USC Roski Eye Institute — Los Angeles, California, United States
- Amy Patel Jain, MD — Newport Beach, California, United States
- Stanford Byers Eye Institute — Palo Alto, California, United States
- Cockerham Eye Consultants, PC — San Diego, California, United States
- Bascom Palmer Eye Institute - Ophthalmology - Miami — Miami, Florida, United States
- Sarasota Retina Institute — Sarasota, Florida, United States
- Northwestern University — Chicago, Illinois, United States
- Family Eye Physicians, Ltd — Oak Lawn, Illinois, United States
- Massachusetts Eye and Ear — Boston, Massachusetts, United States
- Ophthalmic Consultants of Boston — Boston, Massachusetts, United States
- Michigan State University, Department of Neurology — East Lansing, Michigan, United States
- Kahana Oculoplastic and Orbital Surgery — Livonia, Michigan, United States
- Washington University School of Medicine in St Louis - Ophthalmology — St Louis, Missouri, United States
- Steven Leibowitz, MD. — Las Vegas, Nevada, United States
- Rutgers - New Jersey Medical School — Newark, New Jersey, United States
- The Center for Eye and Facial Plastic Surgery — Somerset, New Jersey, United States
- Department of Ophthalmology, University of Pennsylvania — Philadelphia, Pennsylvania, United States
- Wills Eye Hospital — Philadelphia, Pennsylvania, United States
- Baylor College of Medicine (BCM) - Ophthalmology — Houston, Texas, United States
- Neuro Eye Clinical Trials — Houston, Texas, United States
- University of Vermont Medical Center — Burlington, Vermont, United States
- Harborview Medical Center — Seattle, Washington, United States
- North Shore Private Hospital — Saint Leonards, New South Wales, Australia
- CHU Angers — Angers, France
- Advancing Research International, LLC — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.